Labcorp Adds Diagnostics and Drug Development Services

MA_fishAt a time of ongoing M&A activity in the life sciences industry, LabCorp, a leader in diagnostics and laboratory services, has been making some moves on its own. Just yesterday the company announced plans to acquire Covance, a leading global contract research organization (CRO), for an estimated $6 billion. Just a little over a month ago, LabCorp also acquired LipoScience, a company focused on diagnostic technologies for managing cardiovascular disease and diabetes. LabCorp offered an all cash deal for LipoScience valued at approximately $85 million. Continue reading